On these grounds, the ncBAF complex may be targeted at multiple levels in SF3B1MUT CLL beyond BRD9. In addition to these alterations, BAF complex subunits SMARCC1 and ARID1A are deleted or mutated in 2% of CLL cases each [51]. This evidence concerns the gene ARID1A and B-cell chronic lymphocytic leukemia.